Common gout drug may protect organs during major heart surgery
NCT ID NCT06118034
Summary
This large study is testing if a short course of the anti-inflammatory drug colchicine, taken around the time of heart surgery, can reduce damage to organs like the heart and lungs. It will involve 768 patients undergoing planned heart surgery with a heart-lung machine. Researchers will compare patients taking colchicine to those taking a placebo to see if it lowers complications like irregular heartbeats, lung injury, and death.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dong-Jin Wang
RECRUITINGNanjing, Jiangsu, 210008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.